Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Synthetic, nonandrogenic DHEA active in animal model of MS

April 28, 1998

New NK1 receptor antagonist ineffective against postherpetic neuralgia

April 27, 1998

Novo Nordisk sells Seroxat marketing rights to SKB

April 27, 1998

Nitroquinoxalinediones for inhibiting neuronal cell death

April 27, 1998

Generic controlled-release carbamazepine approved in U.K.

April 27, 1998

OHM-3507: a fentanyl derivative with incongruent pharmacological effects

April 24, 1998

AChE inhibitors for Alzheimer's disease disclosed by Sagami

April 24, 1998

Positive phase III results reported for Neurobloc in cervical dystonia

April 24, 1998

Danaparoid sodium is not beneficial for acute ischemic stroke

April 24, 1998

Toray analgesic in clinical development worldwide

April 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...